Salmeterol & Fluticasone 50 μg/250 μg bid in combination provides a better long-term control than salmeterol 50 μg bid alone and placebo in COPD patients already treated with theophylline-Reference-Cited by-同舟云学术

Salmeterol & Fluticasone 50 μg/250 μg bid in combination provides a better long-term control than salmeterol 50 μg bid alone and placebo in COPD patients already treated with theophylline

Published:2003-08 Issue:4 Volume:16 Page:241-246
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Dal Negro Roberto Walter,Pomari Carlo,Tognella Silvia,Micheletto Claudio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference25 articles.

1. Global strategy for the diagnosis management, and prevention of chronic obstructive pulmonary disease;Pawels;Am J Respir Crit Care Med,2001

2. Efficacy of salmeterol xinofoate in the treatment of COPD;Mahler;Chest,1999

3. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease;Boyd;Eur Respir J,1997

4. Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease;Maesen;Eur Respir J,1999

5. Alternative mechanisms for long-acting β2-adrenergic agonists in COPD;Johnson;Chest,2001

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF 6001 on virus‐inducible cytokines;Pharmacology Research & Perspectives;2016-01-15

2. Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2016

3. Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease;International Journal of Chronic Obstructive Pulmonary Disease;2015-04

4. A validated RP-LC method for salmeterol and fluticasone in their binary mixtures and their stress degradation behavior under ICH-recommended stress conditions;Journal of Analytical Chemistry;2014-05-23

5. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis;Cochrane Database of Systematic Reviews;2014-03-26